On Thursday, Costco Wholesale Corporation (NASDAQ:COST)’s shares declined -0.83% to $145.27.
Costco Wholesale Corporation ( COST) declared that its Board of Directors declared a quarterly cash dividend on Costco common stock of $.40 per share. The quarterly dividend is payable August 28, 2015, to shareholders of record at the close of business on August 14, 2015.
Costco presently operates 679 warehouses, counting 479 in the United States and Puerto Rico, 89 in Canada, 36 in Mexico, 26 in the United Kingdom, 20 in Japan, 11 in Korea, 10 in Taiwan, seven in Australia and one in Spain. The Company plans to open up to an additional seven new warehouses proceeding to the end of its fiscal year on August 30, 2015. Costco also operates electronic commerce web sites in the U.S., Canada, the United Kingdom and Mexico.
Costco Wholesale Corporation, together with its auxiliaries, operates membership warehouses. The company offers branded and private-label products in a range of merchandise categories. It provides dry and institutionally packaged foods; snack foods, candy, tobacco, alcoholic and nonalcoholic beverages, and cleaning and institutional supplies; appliances, electronics, health and beauty aids, hardware, garden and patio, and office supplies; meat, bakery, deli, and produce; and apparel, small appliances, and home furnishings.
GLOBAL BLOOD THERAPEUTICS INC COM USD0.001 (NASDAQ:GBT)’s shares dropped -9.46% to $39.03.
Global Blood Therapeutics, Inc. (GBT) is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel, small molecule therapeutics to treat grievous blood-based disorders with noteworthyunmet need. GBT is developing its initial product candidate, GBT440, as an oral, once-daily prophylactic therapy for sickle cell disease (SCD) and is presently evaluating GBT440 in both healthy subjects and SCD patients in a randomized, placebo-controlled, double-blind Phase 1/2 clinical trial. In addition to GBT440 for the treatment of SCD, GBT is engaged in research and development activities targeted toward hypoxemic pulmonary disorders, counting idiopathic pulmonary fibrosis, and hereditary angioedema.
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
At the end of Thursday’s trade, Tribune Media Co (NYSE:TRCO)‘s shares dipped -2.20% to $43.58.
CareerBuilder declared that it has attained a majority stake in Textkernel, a leading-edge software company providing semantic recruitment technology to the global market. The acquisition further supports CareerBuilder’s evolution into an HR software as a service provider and enables Textkernel to accelerate its global growth.
Based in Amsterdam, Textkernel is leading innovation in the field of AI, machine learning and natural language processing in the HR domain. At the core of what Textkernel does is semantic search, which studies the intent and contextual meaning behind words. Employers and job seekers often use different words or phrases to describe the same thing when they type in a search box, write job descriptions or build their resumes/CVs. Textkernel’s advanced technology takes into account language patterns to pinpoint what the user really means in order to provide the best search results.
CareerBuilder works with the world’s top employers, providing job distribution, sourcing, workflow, CRM, data and analytics in one pre-hire platform. Owned by TEGNA Inc. (TGNA), Tribune Media (TRCO) and The McClatchy Company (MNI), CareerBuilder and its auxiliaries operate in the United States, Europe, South America, Canada and Asia. For more information, visit www.careerbuilder.com.
Tribune Media Company, through its auxiliaries, operates as a media and entertainment company in the United States. The company operates through two segments, Television and Entertainment, and Digital and Data. The Television and Entertainment segment provides news, entertainment, and sports programming through Tribune Broadcasting local television stations, counting FOX television associates, CW television associates, CBS television associates, ABC television associates, NBC television associates, and independent television stations; and television series and movies on WGN America, a national general entertainment network.
Atlas Energy Group LLC (NYSE:ATLS), ended its Thursday’s trading session with -6.92% loss, and closed at $3.63.
Atlas Energy Group, LLC (ATLS) declares that it has reached a contract for a new term loan facility maturing in August 2020. The new facility will refinance Atlas Energy’s existing term loan and will have an initial balance of $82.7 million at an interest rate of LIBOR (floor of 1%) plus 7%.
Atlas Energy Group, LLC, through its partner, Atlas Resource Partners, L.P., develops and produces natural gas, crude oil, and natural gas liquids in the United States. It operates through three segments: ARP, New Atlas, and corporate and other. The company has interests in oil and natural gas properties in the Eagle Ford Shale in South Central Atascosa County, Texas, counting 4,000 operated gross acres and net reserves of 12 million barrels of oil equivalent. As of December 31, 2014, it had interests in about 600 wells in the Arkoma Basin in eastern Oklahoma with average daily production of 5.1 million cubic feet equivalent.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
